Severe chickenpox disease and seroprevalence in Sweden - implications for general vaccination

K Widgren1, L Persson Berg2, A Mörner3

  • 1Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden; Department of Public Health Analysis and Data Management, the Public Health Agency of Sweden, Solna, Sweden.

Insights

Severe chickenpox complications occurred in healthy children, supporting universal vaccination. Adult migrants were a hospitalization risk group, with seroprevalence similar to neighboring countries.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Chickenpox (varicella) remains a concern, particularly severe cases requiring hospitalization.
  • Understanding current disease burden and population immunity is crucial for vaccination policy decisions.

Purpose of the Study:

  • To assess the current landscape of severe chickenpox and seroprevalence in Sweden.
  • To provide data supporting the evaluation of universal childhood vaccination strategies.

Main Methods:

  • Retrospective review of hospitalized chickenpox patients (ICD-10 B01-B01.9) in Stockholm and Gothenburg (2012-2014).
  • Analysis of serum samples from 11 Swedish laboratories for varicella-zoster virus IgG antibodies to determine age-specific seroprevalence.

Main Results:

  • Hospitalized cases included 218 children and 46 adults; 87.2% of children and 63.0% of adults experienced complications.
  • Common complications in children were dehydration, bacterial skin infections, and neurological issues. Adult cases frequently involved individuals born abroad.
  • Seroprevalence reached 66.7% by age 5 and 91.5% by age 12. Infants and adolescents/adults were disproportionately represented in hospital admissions compared to seroprevalence data.

Conclusions:

  • The high rate of complications in previously healthy children underscores the benefit of universal childhood vaccination.
  • Adult migrants represent a vulnerable group for severe chickenpox requiring hospitalization.
  • Sweden's age-specific varicella seroprevalence aligns with that of neighboring countries.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
47.2K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
268
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.0K
Cross-reactivity00:42

Cross-reactivity

Overview
31.8K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
11.7K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
532